Archive of Postings to PHARM-POLICY Sorted by Thread

• Date Index

• Venezuela WTO proposal on Essential Drugs, James Love
• Harry Belafonte on South Africa dispute, James Love
• MSF and Bangkok Post: THAILAND A STEP CLOSER TO BECOME FIRST DEVELOPING COUNTRY TO USE COMPULSORY LICENSE, James Love
• EU's response to TACD pharmaceutcial recommendations, James Love
• EC on parallel imports, James Love
• Kristin Dawksin/IATP sign-on letter regarding WTO/TRIPS patent exceptions, James Love
• More news regarding Thailand and ddI compulsory licensing effort, James Love
• MSF on Exclusive Marketing rights in Thailand, James Love
• Letter on Potential Effect of VIRAMUNE (nevirapine) on Methadone., Robert Marshall
• Injunctions under government use/compulsory license - TRIPS provisions and US practice, James Love
• 1993 Executive Order concerning NAFTA and government use of patents, James Love
• Health Cap Coalition Web page, James Love
• Thailand to Negotiate With Bristol-Myers Squibb, James Love
• How are decisions made at the WTO?, James Love
• WTO Working Groups, James Love
• "The Claritin Case How One Firm Played the Patent Game", Thiru Balasubramaniam
• Patrick Bond: Globalization, Pharmaceutical Pricing and South African Health Policy, James Love
• Jean Lanjouw: Introduction of Pharmaceutical Product Patents in India, James Love
• Act Up Paris on Bristol-Myers Squibb: "Secure The Profit" (in English), James Love
• Venezuela Proposal on ED and TRIPS Article 27.3, James Love
• WTO says TRIPS permits CL, PI, price controls and patent exceptions for medical treatment methods, James Love
• US Government Role in HIV/AIDS drugs - from ACTIS and CRISP, James Love
• WTO: NGO discussion on WTO and TRIPS, James Love
• Michigan Cancer Foundation's role in the invention of AZT, ddC and d4T, Thiru Balasubramaniam
• 14 HIV/AIDS drugs - Government Sponsorship of Trials and time to Market, Thiru Balasubramaniam
• typos fixed (including time).. NGO discussion on WTO and TRIPS, James Love
• San Francisco Chronicle piece on AIDS and access to essential medicines, Thiru Balasubramaniam
• Royalty Rates, James Love
• Lawsuit against the Goverment of South Africa (February 18, 1998), Thiru Balasubramaniam
• USTR: DHHS to review 301 issues when health is involved, James Love
• White House statement on New Cooperative Effort to help poor, James Love
• USTR Press release on the web, Thiru Balasubramaniam
• New York Times article (December 2, 1999), Thiru Balasubramaniam
• News regarding SA/USTR/ and other disputes, James Love
• David Sanger, on Clinton annoucement, James Love
• CPT statement on EC/H/J/K/S/T draft TRIPS statement, James Love
• Clionton's speech at WTO, James Love
• "African AIDS Victims Losers of a Drug War U.S. Policy Keeps Prices Prohibitive", Thiru Balasubramaniam
• Clinton gives in on AIDS drugs for 'poor' countries, Thiru Balasubramaniam
• NGO STATEMENT ON WTO CRISIS IN SEATTLE, James Love
• "Agencies urge end to global trade restrictions on essential medicines", Thiru Balasubramaniam
• US to consider poor countries' need for drugs HEALTHCARE CALL FOR END TO TRADE PRESSURES IN HEALTH-RELATED DISPUTES, Thiru Balasubramaniam
• letters from the EU and the UK regarding SA Medicines Act dispute, James Love
• countries with bilaterial trade disputes with the US government, James Love
• Plus Canada, James Love
• Re: Pressure on Dominican Republic, James Love
  • Re: Pressure on Dominican Republic, James Love
• UNAIDS finding, Thiru Balasubramaniam
• 1998 South Africa Court case on compulsory license of patent (request), James Love
• Global Health Council role in new USTR/DHHS reveiw of 301?, James Love
• US AMA Delegates back parallel imports for USA, James Love
• GHC, James Love
• UNAIDS Report on Patents on HIV Drugs in developing countries, James Love
• parallel imports and the Gatt, James Love
• Jon Jeter in Washington Post: AIDS plants crop of death in Africa, James Love
• UNAIDS report on compulsory licensing and access to HIV drugs, James Love
• Note from Joseph Perriens regarding UNAIDS paper, James Love
• CPT slide presentation from Amsterdam meeting, James Love
• AEM meeting on Public-Private role in Biomedical Research, James Love
• Amsterdam Statement to WTO Member States on Access to Medicine, Thiru Balasubramaniam
• Carols Correa and J Watal on parallel import issue, James Love
• Amir Attaran's note on parallel imports and the GATT, James Love
• Gephardt pushes US on AIDS drugs, James Love
• formatting fixed: Amsterdam Statement on WTO members states on access to medicine, James Love
• Thai activists respond to US policy on AIDS drugs, James Love
• Note on EU/Canada dispute over TRIPS 27.1 restrictions on discrimination as to field of technology, James Love
• Overview of the State-of-play of WTO Disputes, Thiru Balasubramaniam
• TRIPS articles 65.5, 70.8 and 70.9, James Love
• EU disputes over parallel imports of Microsoft products, James Love
• More on the 5 year marketing exclusivity and Nevirapine in Thailand, James Love
  • <Possible follow-up(s)>
  • More on the 5 year marketing exclusivity and Nevirapine in Thailand, Thiru Balasubramaniam
• Khalil Elouadighi on Clinton Annoucement, James Love